Consistent dosing: No worrying about inconsistent pill absorption or missed doses
28 A landmark pilot study that investigated the efficacy and safety of 72-h GLP-1 RA infusion in patients with acute MI and impaired LVEF ( 12 weeks) to non-diabetic, overweight or obese individuals with HF (NYHA Class IIIII) and LVEF below 40%
Frequency depends on goals such as injury recovery, post-procedure healing, or anti-aging maintenance
Influence on Muscle Recovery By reducing muscle damage and promoting recovery, L-Carnitine can help individuals maintain a more consistent exercise regimen
Cardiovascular outcome studies Although multiple clinical trials evaluating cardiovascular events associated with GLP-1 RA use as the primary outcome are currently ongoing (Table 1), abundant non-primary outcome data are available from many clinical trials on the efficacy of GLP-1 RAs marketed earlier, such as exenatide (DURATION studies) and liraglutide (LEAD studies)
In agreement with this notion, we found that expression of Glp-1r concentrated in specific neuronal populations, which include two GABAergic neuronal clusters (C35 GABA3 and C35 GABA4) and one glutamatergic neuronal cluster (C35 Glut 8) (Fig